全文获取类型
收费全文 | 1295篇 |
免费 | 87篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 5篇 |
妇产科学 | 33篇 |
基础医学 | 136篇 |
口腔科学 | 17篇 |
临床医学 | 96篇 |
内科学 | 162篇 |
皮肤病学 | 5篇 |
神经病学 | 54篇 |
特种医学 | 85篇 |
外国民族医学 | 3篇 |
外科学 | 93篇 |
综合类 | 13篇 |
预防医学 | 48篇 |
眼科学 | 2篇 |
药学 | 71篇 |
3篇 | |
中国医学 | 8篇 |
肿瘤学 | 553篇 |
出版年
2024年 | 2篇 |
2023年 | 112篇 |
2022年 | 165篇 |
2021年 | 182篇 |
2020年 | 161篇 |
2019年 | 70篇 |
2018年 | 65篇 |
2017年 | 55篇 |
2016年 | 48篇 |
2015年 | 54篇 |
2014年 | 101篇 |
2013年 | 68篇 |
2012年 | 29篇 |
2011年 | 39篇 |
2010年 | 48篇 |
2009年 | 47篇 |
2008年 | 9篇 |
2007年 | 14篇 |
2006年 | 8篇 |
2005年 | 7篇 |
2004年 | 5篇 |
2003年 | 3篇 |
2002年 | 8篇 |
2001年 | 2篇 |
2000年 | 2篇 |
1999年 | 5篇 |
1998年 | 13篇 |
1997年 | 5篇 |
1996年 | 7篇 |
1995年 | 6篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1989年 | 5篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1986年 | 5篇 |
1984年 | 4篇 |
1983年 | 1篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1980年 | 2篇 |
1978年 | 2篇 |
1976年 | 2篇 |
排序方式: 共有1388条查询结果,搜索用时 15 毫秒
1.
《Cancer radiothérapie》2022,26(8):1034-1044
PurposeAssess the feasibility of a randomized controlled trial (RCT) exploring the use of medical imaging as a therapeutic education (TPE) intervention in external radiation therapy.Materials and methodsExperimental feasibility trial of “RCT” type carried out in a single-center, between November 2019 and March 2020, following adult patients treated by thoracic radiotherapy. In addition to the information usually given, the experimental group benefited from an intervention consisting in the visualization of their own medical images using the open-source software “Stone of Orthanc”.ResultsForty-nine patients were recruited with a refusal rate of 8.16% (4/49). 20 patients were withdrawn from the study for health reasons (COVID), 10 for medical reasons. All the remaining 15 participants completed the process. Although not significant, the experimental group showed a median gain in the perception of knowledge compared to the control group (+ 1.9 (1.6 – 2.2)) vs (+ 1.4 (1.4 – 1.8)), as well as a decrease in scores related to anxiety (? 3.0 (?4.5 - (?2.0)) vs ? 1.0 (?5.0 - 0.0)) and emotional distress ((? 5.0 (? 7.5 - (? 3.5)) vs (? 2.0 (? 5.0 - (? 1.0)) A significant reduction (p = 0.043) is observed for the depression score ((? 2.0 (?3.0 - (?1.5)) vs (0.0 (0.0 – 0.0)).ConclusionThis study demonstrates the feasibility of the project, with promising preliminary results. Some adaptations in order to conduct a larger-scale RCT are highlighted. 相似文献
2.
3.
4.
5.
6.
7.
《European journal of surgical oncology》2020,46(6):1118-1123
AimTo investigate the impact of circumferential tumour location on neoadjuvant chemoradiotherapy (CRT) response and its prognostic value for locally advanced rectal cancer (LARC) patients after CRT and surgery.MethodsA retrospective study was performed on 486 patients with LARC who received neoadjuvant CRT and surgical treatment. The rate of pathological complete response (pCR) and survival among patients with anteriorly, laterally, and posteriorly located tumours were compared. Logistic regression was performed to identify pCR predictors.ResultsThe anterior tumours exhibited the highest pCR rate of 26.7%, which was slightly higher than the 20.0% and 12.3% for lateral and posterior tumours, respectively (P = 0.006). The 5-year Overall survival (OS) rates after CRT were similar among the anterior, lateral, and posterior groups (anterior vs lateral vs posterior: 81.1% vs 89.9% vs 84.1%, P = 0.6368). Multivariate analysis revealed that the circumferential tumour location, post-CRT serum CEA and post-CRT tumour thickness measured by MRI were independently correlated with achieving pCR.ConclusionThis study is the first, to the best of our knowledge, to show that anterior LARC exhibited the highest pCR rate after neoadjuvant CRT. Patients with anterior rectal cancers do not have different prognoses from those with non-anterior cancers if they undergo neoadjuvant CRT. 相似文献
8.
9.
10.
拓扑替康、依托泊甙联合顺铂治疗小细胞肺癌的临床观察 总被引:2,自引:0,他引:2
目的:比较拓扑替康、依托泊甙联合顺铂与EP方案治疗小细胞肺癌的临床疗效和毒副反应。方法:患随机分为两组,A组使用TEP方案:TPT0.75~1.25mg/m^2/d,静滴30分钟,d1~5,VP-16 100mg口服或静滴,d2~6,DDP 40mg/d,静滴d1~3;B组使用EP方案:VP-16 100mg静滴或口服d1~5,DDP 40mg/d静滴d1~3。结果:A组14例病例,CR21.43%,PR56.14%,有效率为78.57%;B组13例病例,CR23.08%,PR38.46%,有效率为61.54%。主要毒副反应为血液学毒性及消化道反应。结论:拓扑替康、依托泊甙联合顺铂治疗小细胞肺癌临床效果好,虽然毒副反应较大,但值得进一步研究。 相似文献